A continuous glucose monitor (CGM) changes diabetes management more than almost any other technology. Instead of a reading every few hours, you have a number every 5 minutes, a trend arrow showing where it’s headed, and alerts before a low or high becomes a crisis.
But choosing between the two dominant systems — Dexcom G7 and Abbott FreeStyle Libre 3 — is not straightforward. They’re both good. They’re different in ways that matter for different families. This guide gives you an honest comparison based on real-world pediatric use, not manufacturer marketing.
CGM technology updates frequently. Always confirm current FDA clearance status, age approvals, and your insurance coverage before choosing.
The Short Answer (If You’re in a Hurry)
- Dexcom G7 is the stronger choice if: real-time alerts are your priority, your child has frequent lows, or your child is younger and you need remote monitoring with reliable alarms.
- FreeStyle Libre 3 is the stronger choice if: cost and simplicity matter, your child is older and self-managing, the smaller sensor profile is important, or you’re using it primarily for trend data rather than alarm-driven management.
Neither is universally better. The right system depends on your child’s age, management style, school situation, and budget.
Sensor Size and Wearability
This matters more than spec sheets suggest. A sensor your child refuses to wear is useless.
Dexcom G7 — roughly the size of a large coin, oval-shaped, worn on the upper arm or (for children 2+) the abdomen. The sensor and transmitter are integrated into a single unit, replacing the separate transmitter of the G6. Adhesive patch included; third-party patches available for kids who sweat heavily or swim frequently.
FreeStyle Libre 3 — the smallest CGM currently available for pediatric use. The sensor itself is about the size of two stacked pennies and sits almost flush with the skin. Many children and teens find it significantly less noticeable under clothing, which affects willingness to wear it consistently.
Most endocrinology offices have demo sensors (without the filament) that let children feel the size and placement. A child who won’t tolerate the sensor they’re given will have worse outcomes than one on a “technically inferior” system they actually wear.
Accuracy: What the Numbers Actually Mean
Both systems report accuracy using MARD (Mean Absolute Relative Difference) — the average percentage difference between CGM readings and lab reference values. Lower MARD = more accurate.
| System | Reported MARD (adults) | Reported MARD (children) | Warm-up Time |
|---|---|---|---|
| Dexcom G7 | ~8.2% | ~9.1% | 30 minutes |
| FreeStyle Libre 3 | ~7.8% | ~8.9% | 60 minutes |
Both are clinically accurate enough to make dosing decisions without a fingerstick in most situations — which is a significant shift from earlier CGM generations.
However: MARD is an average. Both systems can be meaningfully inaccurate during:
- Rapid blood sugar changes (when it’s moving fast, the sensor lags)
- Compression events (lying on the sensor at night, disrupting blood flow)
- The first 12–24 hours after insertion (both systems are less accurate initially)
Fingerstick confirmation is still required before any injection decision when the reading seems inconsistent with symptoms, or when the trend arrow and symptoms don’t match. This remains true even with highly accurate CGMs.
Alerts and Alarms: Where Dexcom Has a Clear Lead
This is the category with the clearest differentiation, and it’s important for parents of younger children.
Dexcom G7:
- Customizable high, low, and rate-of-change alerts
- Urgent Low alert at 55 mg/dL that cannot be silenced (safety feature)
- Predictive Low alert — warns 20 minutes before estimated low
- Sounds can be customized; vibration only mode for school
- Alerts transmit to Dexcom Clarity app and compatible smartwatches
FreeStyle Libre 3:
- High and low alerts
- No predictive alerts in standard configuration
- Alert sounds are less configurable
- Alarm volume has been a consistent complaint among parents — “easy to sleep through” is a common review
For parents who check their phone overnight or rely on alerts to wake them, this difference is significant. The Dexcom G7’s predictive alert and its aggressive urgent-low alarm have a measurable impact on nocturnal hypoglycemia detection.
Both CGMs can be delayed by up to 15 minutes during rapid blood sugar changes. An alert at 70 mg/dL may represent blood sugar that is already 55 mg/dL. CGMs complement but do not replace the overnight check protocol your team establishes in the early months.
Remote Monitoring: Watching from School or Work
Dexcom G7 + Dexcom Follow app: Readings share to follower phones in near-real-time (typically under 5 minutes). Followers see readings, trend arrows, and receive alerts if configured. This is the most mature remote monitoring ecosystem available.
FreeStyle Libre 3 + LibreLink + LibreLinkUp: Followers can see readings but with a slight additional lag vs. Dexcom. The follower app is functional but less polished, and alert configuration for followers is more limited.
For parents who want to watch blood sugar from a desk at work while their child is in class, Dexcom’s remote monitoring is more reliable and more informative.
School Use: Practical Considerations
Both systems work at school. The real-world challenges are:
Bluetooth range: The CGM transmits to a phone or receiver. If your child’s phone is in a locker and they’re in class, readings may not transmit reliably. Most teams recommend the phone stay with the child, which requires explicit language in the 504 Plan.
Receiver vs. phone: Dexcom offers a dedicated receiver (no phone required) — useful for children whose schools restrict phones. Libre 3 currently requires a phone or compatible reader.
Notifications in class: Both systems can be set to vibrate only. Teachers should be informed that the device buzzing is a medical alert, not a phone notification, and that the child may need to act immediately.
Compression during PE: Both sensors can show falsely low readings when pressed against equipment (a gymnastics mat, a wrestling move). This is worth discussing with coaches and school nurses.
Cost and Insurance
CGM costs vary enormously by insurance plan. These are rough cash-pay figures that illustrate the structural difference:
| Dexcom G7 | FreeStyle Libre 3 | |
|---|---|---|
| Sensor (10-day wear) | ~$35–45 per sensor | ~$35–45 per sensor |
| Transmitter | Included in sensor | Included in sensor |
| Receiver (optional) | ~$350 one-time | Not available |
| Subscription programs | Dexcom ONE (budget tier) | LibreLink programs vary |
Under most commercial insurance plans with a pediatric T1D diagnosis, both are covered at similar tiers. Libre 3 has historically had lower out-of-pocket costs under Medicare and some state Medicaid programs, though this varies significantly by state.
Always call your insurance’s durable medical equipment (DME) department before assuming coverage. Ask specifically: “Is this CGM covered as DME or pharmacy benefit, and what is my annual deductible for this category?”
Integration with Insulin Pumps
If your child is on or considering a closed-loop insulin delivery system (sometimes called artificial pancreas or hybrid closed loop), this changes the calculation significantly.
- Tandem Control-IQ requires Dexcom G7 (not compatible with Libre)
- Omnipod 5 is compatible with Dexcom G6 and G7
- Medtronic systems use their own proprietary CGM (Guardian 4)
If a specific pump is already in use or planned, the CGM choice may be constrained by that pump’s compatibility.
What Parents Who’ve Used Both Actually Say
The consistent pattern from parent communities:
Parents who switched from Libre to Dexcom most commonly cite: better alerts, better remote monitoring, and catching more overnight lows.
Parents who switched from Dexcom to Libre most commonly cite: sensor cost, smaller size (less visible under clothing for teens), and simpler app for a teen who self-manages and doesn’t want parents watching every reading.
That last point — teen autonomy — is genuinely important. A 15-year-old who resents their parent watching every blood sugar value in real time may deliberately leave their phone in the locker. A system they can manage themselves without constant parental visibility may produce better real-world outcomes than technically superior remote monitoring they actively avoid.
The Decision Framework
Answer these questions to guide your choice:
- Is your child under 8? → Dexcom G7’s alert system and remote monitoring are more important at this age.
- Does your child have frequent severe lows? → Dexcom’s predictive low alert is clinically meaningful.
- Is your child on or considering a Tandem pump? → Dexcom G7, no choice.
- Is your teen self-managing and resistant to parental monitoring? → Libre 3’s simplicity and lower profile may get better real-world adherence.
- Is cost the primary constraint? → Check your specific insurance; don’t assume either is cheaper.
- Does your child swim competitively or do heavy contact sports? → Both are water-resistant; Libre 3’s lower profile may have fewer adhesion issues.
Both are excellent systems. One data point matters most: the best CGM is the one your child will actually wear every day.